MANKIND
MANKIND stock
MANKIND is showing a constructive news setup around Pharmaceuticals, with 4 recent stories and improving sentiment breadth.
MANKIND stock
MANKIND is showing a constructive news setup around Pharmaceuticals, with 4 recent stories and improving sentiment breadth.
MANKIND has built a constructive coverage cluster in the last 28 days. The strongest recurring theme is Pharmaceuticals, while the current weighted impact score is +39 from 3 bullish, 0 bearish, and 1 neutral stories across 4 sources.
MANKIND is last saved at ₹2,540 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is the first public financial report for Mankind Pharma. The company made ₹3230 crore in sales and ₹381 crore in profit. This information helps us understand how much money the company is making and keeping. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 14 days ago · 2 min read
Mint · 22 days ago · 2 min read
Mint · 26 days ago · 2 min read
Economic Times · 4 Jun 2026 · 2 min read
Mint · 21 May 2026 · 2 min read
How MANKIND stacks against related names in this news cluster
MANKIND has appeared across 4 recent stories from 4 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
MANKIND coverage is currently leaning bullish, with 3 bullish, 0 bearish, and 1 neutral analyzed stories in the recent window.
Recent MANKIND coverage is clustering around Pharmaceuticals and Artificial Intelligence. Related names showing up alongside MANKIND include BSE, ERIS, INDIANB.
Use this page as a coverage hub for MANKIND: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
3 recent mentions linked to MANKIND
TopicArtificial Intelligence1 recent mentions linked to MANKIND
StockBSERelated news cluster with 1 links
Latest storyBullish for MANKIND: AI Drug Discovery Partnership Signals GrowthThe Indian pharma sector is increasingly seen as a safe bet amid global turmoil and is poised for mu